SILDENAFIL CITRATE

SILDENAFIL CITRATE was reported 127803 times

These side effects are most commonly reported by patients taking SILDENAFIL CITRATE:

# Side effect Count
0 DYSPNOEA 13449
1 DRUG INEFFECTIVE 12827
2 HEADACHE 10379
3 DEATH 9183
4 DIARRHOEA 7160
5 NAUSEA 6580
6 FATIGUE 6493
7 DIZZINESS 5957
8 PNEUMONIA 5007
9 COUGH 4876
10 MALAISE 4517
11 OFF LABEL USE 3994
12 HYPOTENSION 3837
13 VOMITING 3832
14 PAIN 3823
15 FLUID RETENTION 3406
16 CHEST PAIN 3339
17 PULMONARY ARTERIAL HYPERTENSION 3330
18 CONDITION AGGRAVATED 3236
19 FALL 3148
20 PAIN IN EXTREMITY 3117
21 ASTHENIA 3099
22 PULMONARY HYPERTENSION 3037
23 ERECTION INCREASED 3025
24 FLUSHING 2807
25 OEDEMA PERIPHERAL 2766
26 WEIGHT DECREASED 2745
27 OXYGEN SATURATION DECREASED 2629
28 ARTHRALGIA 2372
29 SYNCOPE 2372
30 DYSPNOEA EXERTIONAL 2339
31 PYREXIA 2338
32 PERIPHERAL SWELLING 2234
33 NASAL CONGESTION 2232
34 PAIN IN JAW 2212
35 NASOPHARYNGITIS 2165
36 DECREASED APPETITE 2145
37 FEELING ABNORMAL 2117
38 ANXIETY 2024
39 BACK PAIN 2021
40 CARDIAC FAILURE 1941
41 WEIGHT INCREASED 1897
42 OEDEMA 1877
43 PALPITATIONS 1874
44 ANAEMIA 1818
45 CARDIAC FAILURE CONGESTIVE 1774
46 INFUSION SITE PAIN 1751
47 INSOMNIA 1739
48 ABDOMINAL DISCOMFORT 1729
49 PRODUCT USE ISSUE 1729
50 HOSPITALISATION 1703
51 RIGHT VENTRICULAR FAILURE 1682
52 MYALGIA 1681
53 CHEST DISCOMFORT 1636
54 RASH 1635
55 RESPIRATORY FAILURE 1603
56 RENAL FAILURE 1588
57 ABDOMINAL PAIN UPPER 1570
58 EPISTAXIS 1552
59 HYPERTENSION 1550
60 ERECTILE DYSFUNCTION 1497
61 HEART RATE INCREASED 1450
62 HYPOXIA 1398
63 LOSS OF CONSCIOUSNESS 1396
64 ATRIAL FIBRILLATION 1385
65 CARDIAC DISORDER 1321
66 PRURITUS 1307
67 CONSTIPATION 1303
68 MYOCARDIAL INFARCTION 1303
69 DEPRESSION 1297
70 ABDOMINAL PAIN 1294
71 MALIGNANT MELANOMA 1280
72 ACUTE KIDNEY INJURY 1276
73 INFLUENZA 1274
74 VISION BLURRED 1268
75 DEHYDRATION 1260
76 DISEASE PROGRESSION 1254
77 PULMONARY OEDEMA 1240
78 DRUG INTERACTION 1208
79 FLUID OVERLOAD 1188
80 SEPSIS 1179
81 BLOOD PRESSURE DECREASED 1178
82 URINARY TRACT INFECTION 1172
83 MUSCLE SPASMS 1168
84 ABDOMINAL DISTENSION 1166
85 CEREBROVASCULAR ACCIDENT 1132
86 INFUSION SITE ERYTHEMA 1103
87 DRUG DOSE OMISSION 1078
88 ERYTHEMA 1073
89 GAIT DISTURBANCE 1069
90 THERAPY NON-RESPONDER 1066
91 PRODUCT DOSE OMISSION ISSUE 1065
92 PRODUCTIVE COUGH 1053
93 INFECTION 1043
94 SWELLING 1041
95 DYSPEPSIA 1038
96 VISUAL IMPAIRMENT 1023
97 SOMNOLENCE 1017
98 HAEMOGLOBIN DECREASED 1016
99 UNEVALUABLE EVENT 1015
100 OROPHARYNGEAL PAIN 1001
101 CHRONIC KIDNEY DISEASE 963
102 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 957
103 CARDIAC ARREST 921
104 GASTROINTESTINAL HAEMORRHAGE 913
105 BRONCHITIS 893
106 TREMOR 892
107 DEVICE RELATED INFECTION 888
108 INCORRECT DOSE ADMINISTERED 880
109 PLEURAL EFFUSION 880
110 LUNG DISORDER 872
111 DRUG EFFECT INCOMPLETE 866
112 EJACULATION DISORDER 862
113 BLOOD PRESSURE INCREASED 857
114 COVID-19 848
115 INTENTIONAL PRODUCT MISUSE 842
116 CHILLS 819
117 MEMORY IMPAIRMENT 816
118 SINUSITIS 808
119 CONFUSIONAL STATE 806
120 GASTROOESOPHAGEAL REFLUX DISEASE 804
121 DRUG INTOLERANCE 802
122 HYPERHIDROSIS 795
123 GENERAL PHYSICAL HEALTH DETERIORATION 789
124 RHINORRHOEA 785
125 HYPOAESTHESIA 779
126 HAEMORRHAGE 777
127 DRUG HYPERSENSITIVITY 768
128 THROAT IRRITATION 766
129 TACHYCARDIA 761
130 MIGRAINE 757
131 HOT FLUSH 743
132 HYPERSENSITIVITY 725
133 PRODUCT USE IN UNAPPROVED INDICATION 710
134 PENIS DISORDER 708
135 ASCITES 702
136 DEVICE DISLOCATION 701
137 DIABETES MELLITUS 694
138 CELLULITIS 691
139 PARAESTHESIA 691
140 JOINT SWELLING 675
141 MUSCULAR WEAKNESS 673
142 ACUTE RESPIRATORY FAILURE 669
143 INTENTIONAL PRODUCT USE ISSUE 668
144 GASTROINTESTINAL DISORDER 664
145 HAEMOPTYSIS 661
146 SEASONAL ALLERGY 658
147 PERICARDIAL EFFUSION 657
148 BLINDNESS 652
149 OVERDOSE 647
150 ILLNESS 643
151 DERMATITIS CONTACT 632
152 PLATELET COUNT DECREASED 628
153 UPPER RESPIRATORY TRACT INFECTION 623
154 INFUSION SITE SWELLING 616
155 CONTUSION 609
156 DEVICE ISSUE 598
157 TRANSFUSION 598
158 ALANINE AMINOTRANSFERASE INCREASED 580
159 THROMBOSIS 580
160 PRESYNCOPE 575
161 DRUG EFFECT DECREASED 573
162 PRODUCT DOSE OMISSION 566
163 FEELING HOT 562
164 OPTIC ISCHAEMIC NEUROPATHY 558
165 DRY MOUTH 553
166 ASPARTATE AMINOTRANSFERASE INCREASED 551
167 BLOOD GLUCOSE INCREASED 548
168 RENAL IMPAIRMENT 539
169 STRESS 530
170 TREATMENT NONCOMPLIANCE 529
171 WHEEZING 526
172 NECK PAIN 523
173 PROSTATE CANCER 517
174 RENAL DISORDER 499
175 BLOOD CREATININE INCREASED 497
176 CATHETER SITE ERYTHEMA 496
177 PULMONARY EMBOLISM 495
178 HYPOACUSIS 494
179 EMOTIONAL DISTRESS 492
180 SEIZURE 483
181 ARTHRITIS 477
182 INJECTION SITE PAIN 471
183 TINNITUS 471
184 VIRAL INFECTION 466
185 LUNG TRANSPLANT 463
186 BLOOD POTASSIUM DECREASED 462
187 CATHETERISATION CARDIAC 462
188 INFUSION SITE INFECTION 462
189 TOXICITY TO VARIOUS AGENTS 461
190 RESPIRATORY DISTRESS 458
191 FLATULENCE 456
192 INFUSION SITE HAEMORRHAGE 456
193 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 455
194 THROMBOCYTOPENIA 455
195 DEVICE LEAKAGE 454
196 ASTHMA 452
197 ARRHYTHMIA 448
198 NEUROPATHY PERIPHERAL 445
199 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 445
200 PENILE PAIN 435
201 SWELLING FACE 435
202 CATARACT 434
203 MUSCULOSKELETAL PAIN 434
204 BALANCE DISORDER 433
205 OXYGEN CONSUMPTION INCREASED 432
206 DYSPHONIA 424
207 LETHARGY 424
208 DRUG ABUSE 421
209 HEAD INJURY 420
210 INFLUENZA LIKE ILLNESS 419
211 LIVER FUNCTION TEST ABNORMAL 419
212 PRODUCT QUALITY ISSUE 416
213 THERAPEUTIC RESPONSE UNEXPECTED 414
214 THERAPY CESSATION 413
215 THERAPY INTERRUPTED 413
216 DYSPHAGIA 412
217 DEVICE OCCLUSION 410
218 DEVICE MALFUNCTION 407
219 DEAFNESS 406
220 SKIN DISCOLOURATION 398
221 MALIGNANT MELANOMA IN SITU 391
222 HAEMATOCHEZIA 390
223 PULMONARY ARTERIAL PRESSURE INCREASED 390
224 AMNESIA 388
225 SINUS DISORDER 388
226 URTICARIA 385
227 VISUAL ACUITY REDUCED 385
228 INTERSTITIAL LUNG DISEASE 384
229 LIVER DISORDER 384
230 CARDIO-RESPIRATORY ARREST 381
231 ADVERSE EVENT 380
232 SUSPECTED COUNTERFEIT PRODUCT 380
233 GOUT 378
234 ROAD TRAFFIC ACCIDENT 376
235 NEOPLASM MALIGNANT 374
236 CYANOPSIA 373
237 HYPERVOLAEMIA 367
238 CYANOSIS 364
239 DYSURIA 363
240 CATHETER SITE PAIN 361
241 RECTAL HAEMORRHAGE 361
242 BRADYCARDIA 360
243 RESPIRATORY DISORDER 360
244 SEPTIC SHOCK 354
245 END STAGE RENAL DISEASE 352
246 COMPLICATION ASSOCIATED WITH DEVICE 350
247 HEART RATE DECREASED 348
248 BLOOD CHOLESTEROL INCREASED 347
249 POLLAKIURIA 347
250 HIP FRACTURE 346
251 SCLERODERMA 341
252 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 340
253 HYPOKALAEMIA 340
254 SLEEP DISORDER 340
255 ALOPECIA 339
256 BURNING SENSATION 339
257 STAPHYLOCOCCAL INFECTION 339
258 HERPES ZOSTER 336
259 PREMATURE BABY 333
260 LOCALISED INFECTION 332
261 BLOOD BILIRUBIN INCREASED 330
262 SURGERY 330
263 DRY SKIN 328
264 SINUS CONGESTION 327
265 CORONARY ARTERY DISEASE 326
266 NERVOUSNESS 323
267 EYE PAIN 322
268 ARTHROPATHY 321
269 VASCULAR DEVICE INFECTION 320
270 DEPRESSED MOOD 316
271 TRANSIENT ISCHAEMIC ATTACK 314
272 INJURY 313
273 DIALYSIS 312
274 OCULAR HYPERAEMIA 311
275 MUSCULOSKELETAL STIFFNESS 308
276 BLINDNESS UNILATERAL 307
277 CATHETER SITE INFECTION 306
278 INFUSION SITE DISCHARGE 306
279 CENTRAL VENOUS CATHETERISATION 304
280 BLOOD ALKALINE PHOSPHATASE INCREASED 303
281 HEART RATE IRREGULAR 303
282 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 302
283 VERTIGO 302
284 AGITATION 298
285 INTERNATIONAL NORMALISED RATIO INCREASED 298
286 RENAL FAILURE ACUTE 296
287 BONE PAIN 295
288 FOETAL EXPOSURE DURING PREGNANCY 295
289 BLOOD PRESSURE ABNORMAL 292
290 INJECTION SITE ERYTHEMA 292
291 ACUTE MYOCARDIAL INFARCTION 291
292 SLEEP APNOEA SYNDROME 290
293 COMA 289
294 DISCOMFORT 289
295 RESPIRATORY TRACT INFECTION 288
296 SKIN ULCER 287
297 NEPHROLITHIASIS 286
298 CATHETER SITE PRURITUS 285
299 DEEP VEIN THROMBOSIS 284
300 DIZZINESS POSTURAL 284
301 GASTRIC DISORDER 284
302 DEVICE INFUSION ISSUE 283
303 RESPIRATORY TRACT CONGESTION 283
304 MOBILITY DECREASED 280
305 CATHETER MANAGEMENT 279
306 RASH PRURITIC 278
307 INFUSION SITE PRURITUS 276
308 WHITE BLOOD CELL COUNT DECREASED 275
309 LIMB INJURY 274
310 PULMONARY FIBROSIS 274
311 CARDIOMEGALY 273
312 CATHETER SITE HAEMORRHAGE 273
313 ADVERSE DRUG REACTION 272
314 ANHEDONIA 272
315 EXERCISE TOLERANCE DECREASED 272
316 RETCHING 272
317 ATRIAL FLUTTER 270
318 CATHETER SITE DISCHARGE 268
319 DYSGEUSIA 267
320 SYSTEMIC LUPUS ERYTHEMATOSUS 267
321 SUICIDAL IDEATION 266
322 MENTAL STATUS CHANGES 265
323 CEREBRAL HAEMORRHAGE 264
324 HEPATIC ENZYME INCREASED 263
325 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 261
326 MATERNAL EXPOSURE DURING PREGNANCY 260
327 HYPERSOMNIA 259
328 INTENTIONAL OVERDOSE 256
329 PULMONARY CONGESTION 256
330 CARDIAC OPERATION 255
331 OSTEOPOROSIS 255
332 GASTROENTERITIS VIRAL 254
333 CLOSTRIDIUM DIFFICILE INFECTION 253
334 HEPATIC CIRRHOSIS 252
335 CARDIOGENIC SHOCK 251
336 EXPOSURE DURING PREGNANCY 251
337 HYPONATRAEMIA 249
338 ANGINA PECTORIS 248
339 LIMB DISCOMFORT 248
340 NO ADVERSE EVENT 246
341 HEAD DISCOMFORT 244
342 HAEMATOCRIT DECREASED 243
343 PNEUMOTHORAX 241
344 EYE DISORDER 239
345 HALLUCINATION 238
346 LOWER RESPIRATORY TRACT INFECTION 235
347 PANCREATITIS 235
348 CONCOMITANT DISEASE AGGRAVATED 233
349 DEVICE FAILURE 233
350 EAR INFECTION 232
351 INTESTINAL OBSTRUCTION 232
352 EXPIRED PRODUCT ADMINISTERED 230
353 HAEMATEMESIS 230
354 BLISTER 227
355 FEELING COLD 227
356 RIB FRACTURE 227
357 CHOLELITHIASIS 226
358 PREMATURE DELIVERY 226
359 PHOTOPHOBIA 225
360 SPEECH DISORDER 225
361 PRIAPISM 224
362 DIVERTICULITIS 223
363 HYPOGLYCAEMIA 223
364 DEVICE ALARM ISSUE 222
365 OSTEOARTHRITIS 222
366 WHITE BLOOD CELL COUNT INCREASED 221
367 DISTURBANCE IN ATTENTION 220
368 PRE-EXISTING CONDITION IMPROVED 220
369 PALLOR 219
370 BLOOD GLUCOSE DECREASED 217
371 CYSTITIS 216
372 THERAPY CHANGE 216
373 BLOOD IRON DECREASED 215
374 CIRCULATORY COLLAPSE 215
375 RED BLOOD CELL COUNT DECREASED 215
376 HEPATIC FAILURE 214
377 DEVICE BREAKAGE 213
378 HYPERKALAEMIA 213
379 PANIC ATTACK 213
380 VENTRICULAR TACHYCARDIA 211
381 INFUSION SITE INDURATION 210
382 IRRITABILITY 210
383 MENTAL DISORDER 209
384 DIPLOPIA 207
385 ECONOMIC PROBLEM 207
386 CARDIAC FAILURE ACUTE 206
387 PRODUCT SUBSTITUTION ISSUE 206
388 GENERALISED OEDEMA 205
389 PANCYTOPENIA 205
390 DRUG DEPENDENCE 204
391 INFUSION SITE REACTION 204
392 BRAIN NATRIURETIC PEPTIDE INCREASED 202
393 EYE SWELLING 201
394 MEDICATION ERROR 201
395 UNRESPONSIVE TO STIMULI 201
396 SNEEZING 200
397 INTENTIONAL DOSE OMISSION 199
398 LACRIMATION INCREASED 199
399 RESPIRATORY ARREST 199
400 DISORIENTATION 198
401 INFUSION SITE WARMTH 198
402 INTERNAL HAEMORRHAGE 198
403 HAEMATURIA 197
404 HAEMOGLOBIN INCREASED 197
405 SPINAL FRACTURE 197
406 DYSPNOEA AT REST 196
407 RENAL INJURY 196
408 RESPIRATION ABNORMAL 196
409 RHEUMATOID ARTHRITIS 196
410 SUDDEN DEATH 195
411 CONVULSION 194
412 FAECES DISCOLOURED 194
413 PAINFUL ERECTION 194
414 INFUSION SITE IRRITATION 193
415 JOINT INJURY 193
416 LIVER FUNCTION TEST INCREASED 193
417 HERNIA 192
418 VISUAL FIELD DEFECT 192
419 EXTRA DOSE ADMINISTERED 191
420 DEVICE USE ERROR 190
421 ILL-DEFINED DISORDER 190
422 MULTIPLE ORGAN DYSFUNCTION SYNDROME 190
423 CATHETER PLACEMENT 189
424 POOR QUALITY SLEEP 189
425 POST PROCEDURAL COMPLICATION 189
426 TRICUSPID VALVE INCOMPETENCE 188
427 URINARY RETENTION 188
428 TYPE 2 DIABETES MELLITUS 187
429 BACTERIAL INFECTION 186
430 LUNG NEOPLASM MALIGNANT 186
431 SECRETION DISCHARGE 186
432 ACCIDENTAL OVERDOSE 185
433 EJACULATION FAILURE 184
434 MELAENA 183
435 RESPIRATORY SYNCYTIAL VIRUS INFECTION 183
436 COGNITIVE DISORDER 182
437 LIP SWELLING 182
438 MUSCULOSKELETAL CHEST PAIN 181
439 BLOOD SODIUM DECREASED 180
440 GLAUCOMA 180
441 LOWER LIMB FRACTURE 180
442 UPPER LIMB FRACTURE 180
443 RESTLESS LEGS SYNDROME 179
444 BACTERAEMIA 178
445 LABORATORY TEST ABNORMAL 177
446 GASTRITIS 175
447 HAEMATOMA 175
448 BACK DISORDER 174
449 RALES 174
450 IRON DEFICIENCY ANAEMIA 173
451 PRODUCT ADMINISTRATION INTERRUPTED 173
452 PNEUMONIA ASPIRATION 172
453 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 172
454 SKIN IRRITATION 172
455 HAEMORRHOIDS 171
456 INTERVERTEBRAL DISC PROTRUSION 171
457 LUNG INFECTION 171
458 PURULENT DISCHARGE 171
459 JAUNDICE 169
460 NEURALGIA 169
461 PULMONARY HAEMORRHAGE 168
462 NEPHROGENIC ANAEMIA 167
463 SPUTUM DISCOLOURED 167
464 COMPLETED SUICIDE 166
465 GAIT INABILITY 166
466 WOUND 166
467 BLOOD POTASSIUM INCREASED 165
468 BLOOD PRESSURE FLUCTUATION 165
469 DECREASED ACTIVITY 165
470 INFLAMMATION 165
471 PRESCRIBED OVERDOSE 165
472 NIGHT SWEATS 164
473 PULMONARY THROMBOSIS 163
474 SKIN EXFOLIATION 163
475 DYSARTHRIA 162
476 HEPATIC FUNCTION ABNORMAL 162
477 THERAPEUTIC RESPONSE DECREASED 162
478 BLOOD UREA INCREASED 160
479 PREMATURE EJACULATION 160
480 URINARY INCONTINENCE 160
481 CATHETER SITE SWELLING 159
482 GALLBLADDER DISORDER 159
483 MUSCULOSKELETAL DISCOMFORT 159
484 RASH ERYTHEMATOUS 158
485 RHABDOMYOLYSIS 158
486 ANGIOEDEMA 157
487 BLOOD TESTOSTERONE DECREASED 157
488 CARDIAC PACEMAKER INSERTION 157
489 DRUG EFFECT DELAYED 156
490 EAR DISCOMFORT 156
491 LYMPHADENOPATHY 156
492 AGGRESSION 155
493 RASH MACULAR 155
494 RHINOVIRUS INFECTION 155
495 SUBDURAL HAEMATOMA 155
496 DRUG ADMINISTRATION ERROR 154
497 DYSSTASIA 154
498 BLOOD URINE PRESENT 153
499 PENILE SWELLING 153
500 CORONARY ARTERY OCCLUSION 152
501 DEAFNESS UNILATERAL 152
502 FOOT FRACTURE 152
503 INJECTION SITE PRURITUS 152
504 SUBARACHNOID HAEMORRHAGE 152
505 TOOTHACHE 152
506 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 151
507 INTENTIONAL DRUG MISUSE 151
508 KIDNEY INFECTION 151
509 WEIGHT FLUCTUATION 150
510 FUNGAL INFECTION 149
511 LOCALISED OEDEMA 149
512 STOMATITIS 149
513 SUPRAVENTRICULAR TACHYCARDIA 149
514 MULTI-ORGAN FAILURE 148
515 SKIN DISORDER 148
516 SUICIDE ATTEMPT 148
517 FREQUENT BOWEL MOVEMENTS 147
518 INJECTION SITE DISCHARGE 147
519 INJECTION SITE HAEMORRHAGE 147
520 EYE IRRITATION 146
521 MITRAL VALVE INCOMPETENCE 146
522 GAMMA-GLUTAMYLTRANSFERASE INCREASED 144
523 PROSTATIC DISORDER 144
524 SHOCK 144
525 AGEUSIA 143
526 BACK INJURY 143
527 EYE HAEMORRHAGE 143
528 OXYGEN SATURATION ABNORMAL 143
529 BASAL CELL CARCINOMA 142
530 EAR PAIN 142
531 CHOKING 141
532 THROMBOSIS IN DEVICE 141
533 DRY EYE 140
534 FEELING JITTERY 140
535 SEXUAL DYSFUNCTION 140
536 ANKLE FRACTURE 139
537 PULMONARY VENO-OCCLUSIVE DISEASE 139
538 CHROMATURIA 138
539 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 138
540 BLOOD COUNT ABNORMAL 137
541 DEVICE RELATED SEPSIS 137
542 THERAPY PARTIAL RESPONDER 137
543 UPPER GASTROINTESTINAL HAEMORRHAGE 137
544 COAGULOPATHY 136
545 PSORIASIS 136
546 FACIAL PAIN 135
547 HYPERLIPIDAEMIA 135
548 RESTLESSNESS 135
549 ANORGASMIA 134
550 STENT PLACEMENT 134
551 ATELECTASIS 133
552 DEPRESSED LEVEL OF CONSCIOUSNESS 133
553 SKIN INFECTION 132
554 BODY TEMPERATURE INCREASED 131
555 INJECTION SITE SWELLING 131
556 C-REACTIVE PROTEIN INCREASED 130
557 DEVICE MAINTENANCE ISSUE 130
558 ISCHAEMIC STROKE 130
559 OBESITY 129
560 CARDIOMYOPATHY 128
561 FLANK PAIN 128
562 MEDICAL DEVICE COMPLICATION 128
563 THROAT TIGHTNESS 128
564 FEEDING DISORDER 127
565 HYPERGLYCAEMIA 127
566 ORTHOSTATIC HYPOTENSION 127
567 UNDERDOSE 127
568 ABNORMAL BEHAVIOUR 126
569 BLOOD CREATINE PHOSPHOKINASE INCREASED 126
570 DEMENTIA 126
571 DRY THROAT 126
572 OSTEOPENIA 126
573 BEDRIDDEN 125
574 COLD SWEAT 125
575 COLON CANCER 125
576 EATING DISORDER 125
577 INFUSION SITE OEDEMA 125
578 INFUSION SITE RASH 125
579 PERIPHERAL COLDNESS 125
580 SCIATICA 125
581 SUBSTANCE USE DISORDER 125
582 BONE DENSITY DECREASED 124
583 COLITIS 124
584 SKIN LACERATION 124
585 DRUG WITHDRAWAL SYNDROME 123
586 ENCEPHALOPATHY 123
587 PULMONARY MASS 123
588 TRANSPLANT EVALUATION 123
589 ELECTROLYTE IMBALANCE 122
590 HOSPICE CARE 122
591 RAYNAUD^S PHENOMENON 122
592 TERMINAL STATE 122
593 TUBULOINTERSTITIAL NEPHRITIS 122
594 HYPOPHAGIA 121
595 METABOLIC ACIDOSIS 121
596 MUSCLE STRAIN 121
597 BLINDNESS TRANSIENT 120
598 FEAR 120
599 NEUTROPENIA 120
600 ORTHOPNOEA 120
601 THIRST 120
602 BRONCHOSPASM 119
603 EMPHYSEMA 119
604 EYE PRURITUS 119
605 HEARING IMPAIRED 119
606 IMPAIRED HEALING 119
607 LIBIDO DECREASED 119
608 METASTATIC MALIGNANT MELANOMA 119
609 CEREBRAL INFARCTION 118
610 EMOTIONAL DISORDER 118
611 BLOOD PRESSURE SYSTOLIC DECREASED 117
612 CHOKING SENSATION 117
613 MULTIPLE SCLEROSIS 117
614 RIGHT VENTRICULAR DYSFUNCTION 117
615 DIABETES MELLITUS INADEQUATE CONTROL 116
616 LIVER TRANSPLANT 116
617 NASAL DRYNESS 116
618 ULCER 116
619 BENIGN PROSTATIC HYPERPLASIA 115
620 ORAL CANDIDIASIS 115
621 ROTATOR CUFF SYNDROME 115
622 SWOLLEN TONGUE 115
623 THERAPEUTIC PRODUCT EFFECT DECREASED 115
624 TREATMENT FAILURE 115
625 ACCIDENTAL EXPOSURE TO PRODUCT 114
626 CARDIAC FAILURE CHRONIC 114
627 APHASIA 113
628 CARDIOVASCULAR DISORDER 113
629 DEVICE CONNECTION ISSUE 113
630 HAEMODYNAMIC INSTABILITY 113
631 HEPATOMEGALY 113
632 HIP ARTHROPLASTY 113
633 LEFT VENTRICULAR FAILURE 113
634 NO THERAPEUTIC RESPONSE 113
635 BRAIN FOG 112
636 CRYING 112
637 LIGAMENT SPRAIN 112
638 TOOTH INFECTION 112
639 CARDIAC FLUTTER 111
640 CATHETER SITE RASH 111
641 FACE OEDEMA 111
642 MACULAR DEGENERATION 111
643 MOOD ALTERED 111
644 ACUTE RESPIRATORY DISTRESS SYNDROME 110
645 HEMIPARESIS 110
646 RETINAL VEIN OCCLUSION 110
647 VENTRICULAR FIBRILLATION 110
648 VISUAL DISTURBANCE 110
649 GASTROENTERITIS 109
650 PRODUCT DOSE OMISSION IN ERROR 109
651 TESTICULAR DISORDER 109
652 TOOTH DISORDER 109
653 ACCIDENT 108
654 ERUCTATION 108
655 FEMUR FRACTURE 108
656 INFUSION SITE DISCOMFORT 108
657 MUSCLE TIGHTNESS 108
658 MUSCLE TWITCHING 108
659 INFUSION SITE NODULE 107
660 LOCAL SWELLING 107
661 PNEUMONIA BACTERIAL 107
662 SINUS TACHYCARDIA 107
663 SLUGGISHNESS 107
664 ANGER 106
665 BLOOD TRIGLYCERIDES INCREASED 106
666 HYPERTHYROIDISM 106
667 TASTE DISORDER 106
668 GASTRIC ULCER 105
669 BLOOD PRESSURE SYSTOLIC INCREASED 104
670 ORAL PAIN 104
671 POST PROCEDURAL HAEMORRHAGE 104
672 SPONTANEOUS PENILE ERECTION 104
673 ACTIVITIES OF DAILY LIVING IMPAIRED 103
674 DISEASE COMPLICATION 103
675 INFUSION SITE DISCOLOURATION 103
676 MALIGNANT MELANOMA STAGE IV 103
677 SKIN LESION 103
678 URINE OUTPUT DECREASED 103
679 DEVICE POWER SOURCE ISSUE 102
680 INJECTION SITE INFECTION 102
681 SEMEN VOLUME INCREASED 102
682 TACHYPNOEA 102
683 COR PULMONALE 101
684 HIATUS HERNIA 101
685 PULMONARY HYPERTENSIVE CRISIS 101
686 SCAR 101
687 SMALL INTESTINAL OBSTRUCTION 101
688 DYSKINESIA 100
689 GLYCOSYLATED HAEMOGLOBIN INCREASED 100
690 PROSTATIC SPECIFIC ANTIGEN INCREASED 100
691 BODY HEIGHT DECREASED 99
692 CANDIDA INFECTION 99
693 KNEE ARTHROPLASTY 99
694 MYOCARDIAL ISCHAEMIA 99
695 SQUAMOUS CELL CARCINOMA 99
696 AMMONIA INCREASED 98
697 ASPIRATION 98
698 CHRONIC RESPIRATORY FAILURE 98
699 HYPOTHYROIDISM 98
700 LACERATION 98
701 MENTAL IMPAIRMENT 98
702 OROPHARYNGEAL DISCOMFORT 98
703 PHOTOPSIA 98
704 UPPER-AIRWAY COUGH SYNDROME 98
705 ABASIA 97
706 ABSCESS 97
707 CARDIAC MURMUR 97
708 MULTIPLE ALLERGIES 97
709 MUSCULOSKELETAL DISORDER 97
710 OSTEOMYELITIS 97
711 APHONIA 96
712 HEPATIC STEATOSIS 96
713 NIGHTMARE 96
714 RESPIRATORY RATE INCREASED 96
715 SKIN BURNING SENSATION 96
716 ABDOMINAL PAIN LOWER 95
717 CATHETER SITE IRRITATION 95
718 DELIRIUM 95
719 GASTRIC HAEMORRHAGE 95
720 IMPAIRED GASTRIC EMPTYING 95
721 INFUSION SITE EXTRAVASATION 95
722 MOVEMENT DISORDER 95
723 PANCREATITIS ACUTE 95
724 PENILE HAEMORRHAGE 95
725 TROPONIN INCREASED 95
726 ATRIAL TACHYCARDIA 94
727 CHROMATOPSIA 94
728 DEVICE DIFFICULT TO USE 94
729 PARKINSON^S DISEASE 94
730 EXPIRED DRUG ADMINISTERED 93
731 HEART TRANSPLANT 93
732 HEPATIC ENCEPHALOPATHY 93
733 LIVER INJURY 93
734 MECHANICAL VENTILATION 93
735 PRODUCT ADMINISTRATION ERROR 93
736 BLOOD MAGNESIUM DECREASED 92
737 DEVICE WIRELESS COMMUNICATION ISSUE 92
738 GYNAECOMASTIA 92
739 NERVE INJURY 92
740 NEUTROPHIL COUNT INCREASED 92
741 TOOTH ABSCESS 92
742 CARDIAC VALVE DISEASE 91
743 DEVICE PHYSICAL PROPERTY ISSUE 91
744 JOINT STIFFNESS 91
745 POLYURIA 91
746 THYROID DISORDER 91
747 TOOTH LOSS 91
748 TRANSAMINASES INCREASED 91
749 ANAPHYLACTIC REACTION 90
750 CLOSTRIDIUM DIFFICILE COLITIS 90
751 CONTRAINDICATED PRODUCT ADMINISTERED 90
752 EJECTION FRACTION DECREASED 90
753 FAECES SOFT 90
754 PARANASAL SINUS DISCOMFORT 90
755 PRODUCT PRESCRIBING ERROR 90
756 ANOSMIA 89
757 CARBON DIOXIDE INCREASED 89
758 PARANASAL SINUS HYPERSECRETION 89
759 VAGINAL HAEMORRHAGE 89
760 BREAST CANCER 88
761 CHOLECYSTECTOMY 88
762 ENDOTRACHEAL INTUBATION 88
763 FRACTURE 88
764 HYPERPARATHYROIDISM SECONDARY 88
765 INFUSION RELATED REACTION 88
766 PROSTATOMEGALY 88
767 RETINAL DETACHMENT 88
768 DEVICE USE ISSUE 87
769 MOOD SWINGS 87
770 PNEUMONITIS 87
771 VASODILATATION 87
772 BLOOD CULTURE POSITIVE 86
773 HEART RATE ABNORMAL 86
774 INFUSION SITE BRUISING 86
775 NOCTURIA 86
776 PULSELESS ELECTRICAL ACTIVITY 86
777 VIRAL UPPER RESPIRATORY TRACT INFECTION 86
778 WRONG TECHNIQUE IN DRUG USAGE PROCESS 86
779 CARDIAC ABLATION 85
780 CHOLECYSTITIS 85
781 FULL BLOOD COUNT DECREASED 85
782 HAEMORRHAGE INTRACRANIAL 85
783 INFUSION SITE INFLAMMATION 85
784 MALNUTRITION 85
785 NASAL DISCOMFORT 85
786 TESTICULAR PAIN 85
787 WALKING DISTANCE TEST ABNORMAL 85
788 WRIST FRACTURE 85
789 COVID-19 PNEUMONIA 84
790 LOSS OF LIBIDO 84
791 PREGNANCY 84
792 RENAL FAILURE CHRONIC 84
793 SELF-MEDICATION 84
794 GINGIVAL BLEEDING 83
795 INJECTION SITE REACTION 83
796 MALIGNANT MELANOMA STAGE I 83
797 PULMONARY PAIN 83
798 ARTERIAL OCCLUSIVE DISEASE 82
799 CARPAL TUNNEL SYNDROME 82
800 IMPAIRED WORK ABILITY 82
801 INTERVERTEBRAL DISC DEGENERATION 82
802 OSTEONECROSIS 82
803 PERICARDITIS 82
804 PLASMA CELL MYELOMA 82
805 SARCOIDOSIS 82
806 SINUS HEADACHE 82
807 ARTHROPOD BITE 81
808 BLOOD GLUCOSE ABNORMAL 81
809 DISEASE RECURRENCE 81
810 ECZEMA 81
811 FIBROMYALGIA 81
812 IRRITABLE BOWEL SYNDROME 81
813 MULTIPLE SCLEROSIS RELAPSE 81
814 PAIN OF SKIN 81
815 PROCEDURAL PAIN 81
816 PULMONARY ALVEOLAR HAEMORRHAGE 81
817 RETINAL HAEMORRHAGE 81
818 TENSION HEADACHE 81
819 UNINTENTIONAL MEDICAL DEVICE REMOVAL 81
820 VITREOUS FLOATERS 81
821 CATHETER SITE INFLAMMATION 80
822 DRUG TOLERANCE DECREASED 80
823 GENERALISED TONIC-CLONIC SEIZURE 80
824 OXYGEN THERAPY 80
825 PELVIC FRACTURE 80
826 PRODUCT LEAKAGE 80
827 PRURITUS GENITAL 80
828 SPLENOMEGALY 80
829 TENDERNESS 80
830 ARTERIOSCLEROSIS CORONARY ARTERY 79
831 BLADDER CANCER 79
832 BONE DISORDER 79
833 FEBRILE NEUTROPENIA 79
834 OCULAR DISCOMFORT 79
835 PRODUCT DISPENSING ERROR 79
836 ACTINIC KERATOSIS 78
837 DEAFNESS NEUROSENSORY 78
838 EYE INFECTION 78
839 HYPERCAPNIA 78
840 PARACENTESIS 78
841 DISABILITY 77
842 HEPATITIS 77
843 MALIGNANT MELANOMA STAGE II 77
844 MALIGNANT MELANOMA STAGE III 77
845 NERVOUS SYSTEM DISORDER 77
846 PHARYNGITIS 77
847 VASCULITIS 77
848 BRAIN INJURY 76
849 CARDIOPULMONARY FAILURE 76
850 CARDIOVERSION 76
851 CHOLESTASIS 76
852 DRUG DISPENSING ERROR 76
853 INFUSION SITE CELLULITIS 76
854 INFUSION SITE VESICLES 76
855 MIDDLE INSOMNIA 76
856 NEPHROPATHY 76
857 NERVE COMPRESSION 76
858 RASH PAPULAR 76
859 SKIN CANCER 76
860 ANAL INCONTINENCE 75
861 BREATH SOUNDS ABNORMAL 75
862 COLITIS ULCERATIVE 75
863 GROIN PAIN 75
864 HEPATOTOXICITY 75
865 RENAL TUBULAR NECROSIS 75
866 TOOTH EXTRACTION 75
867 HAEMORRHOIDAL HAEMORRHAGE 74
868 INJECTION SITE BRUISING 74
869 LARGE INTESTINE POLYP 74
870 PARANOIA 74
871 RASH GENERALISED 74
872 RIGHT VENTRICULAR DILATATION 74
873 TESTICULAR SWELLING 74
874 HAEMODIALYSIS 73
875 LEUKOCYTOSIS 73
876 LEUKOPENIA 73
877 LUNG INFILTRATION 73
878 BLOOD DISORDER 72
879 CAROTID ARTERY OCCLUSION 72
880 ELECTROCARDIOGRAM ABNORMAL 72
881 GLOMERULAR FILTRATION RATE DECREASED 72
882 HEPATIC CONGESTION 72
883 HYPOVOLAEMIA 72
884 MASS 72
885 PHARYNGITIS STREPTOCOCCAL 72
886 PROCEDURAL COMPLICATION 72
887 PRODUCT PHYSICAL ISSUE 72
888 REBOUND ACID HYPERSECRETION 72
889 SARS-COV-2 TEST POSITIVE 72
890 TEMPERATURE INTOLERANCE 72
891 LARYNGITIS 71
892 MANIA 71
893 QUALITY OF LIFE DECREASED 71
894 RETINAL ARTERY OCCLUSION 71
895 ABNORMAL DREAMS 70
896 CONCOMITANT DISEASE PROGRESSION 70
897 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70
898 DRUG TITRATION ERROR 70
899 EMERGENCY CARE 70
900 LOW BIRTH WEIGHT BABY 70
901 LOWER GASTROINTESTINAL HAEMORRHAGE 70
902 MENORRHAGIA 70
903 PETECHIAE 70
904 POST-TRAUMATIC STRESS DISORDER 70
905 ARTERIOSCLEROSIS 69
906 BLOOD TEST ABNORMAL 69
907 COMPRESSION FRACTURE 69
908 DIABETIC NEUROPATHY 69
909 DRUG-INDUCED LIVER INJURY 69
910 PHARMACEUTICAL PRODUCT COMPLAINT 69
911 PHOTOSENSITIVITY REACTION 69
912 SPINAL OSTEOARTHRITIS 69
913 ALTERED STATE OF CONSCIOUSNESS 68
914 ASPHYXIA 68
915 AUTOIMMUNE DISORDER 68
916 HYPOAESTHESIA ORAL 68
917 HYPOKINESIA 68
918 IDIOPATHIC PULMONARY FIBROSIS 68
919 MICTURITION URGENCY 68
920 MOUTH HAEMORRHAGE 68
921 MULTIPLE FRACTURES 68
922 PACKED RED BLOOD CELL TRANSFUSION 68
923 RENAL CYST 68
924 THINKING ABNORMAL 68
925 KNEE OPERATION 67
926 MYOPATHY 67
927 ABNORMAL LOSS OF WEIGHT 66
928 CORONARY ARTERY STENOSIS 66
929 INCONTINENCE 66
930 LACTIC ACIDOSIS 66
931 MUSCLE ATROPHY 66
932 SUDDEN CARDIAC DEATH 66
933 CATARACT OPERATION 65
934 CATHETER SITE RELATED REACTION 65
935 CHORIORETINOPATHY 65
936 EPILEPSY 65
937 LEFT VENTRICULAR DYSFUNCTION 65
938 STAPHYLOCOCCAL BACTERAEMIA 65
939 VENTRICULAR EXTRASYSTOLES 65
940 WOUND INFECTION 65
941 BIPOLAR DISORDER 64
942 CAESAREAN SECTION 64
943 DERMATITIS 64
944 HEPATITIS C 64
945 INJECTION SITE IRRITATION 64
946 INTERNATIONAL NORMALISED RATIO DECREASED 64
947 NOCTURNAL DYSPNOEA 64
948 POOR PERIPHERAL CIRCULATION 64
949 TRACHEOSTOMY 64
950 VENTILATION PERFUSION MISMATCH 64
951 ACUTE PULMONARY OEDEMA 63
952 AORTIC ANEURYSM 63
953 APATHY 63
954 HERNIA REPAIR 63
955 HYPOMAGNESAEMIA 63
956 INJECTION SITE RASH 63
957 MACULOPATHY 63
958 OBSTRUCTIVE AIRWAYS DISORDER 63
959 ONYCHOMYCOSIS 63
960 RHINITIS ALLERGIC 63
961 SPINAL COMPRESSION FRACTURE 63
962 WITHDRAWAL SYNDROME 63
963 APPLICATION SITE PRURITUS 62
964 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62
965 CONCUSSION 62
966 LEFT VENTRICULAR HYPERTROPHY 62
967 OBSESSIVE-COMPULSIVE DISORDER 62
968 PAPILLOEDEMA 62
969 PRODUCT COUNTERFEIT 62
970 STAPHYLOCOCCUS TEST POSITIVE 62
971 APPETITE DISORDER 61
972 CARDIAC TAMPONADE 61
973 ENDOCARDITIS 61
974 GASTROINTESTINAL INFECTION 61
975 GLOSSODYNIA 61
976 INCORRECT DRUG ADMINISTRATION RATE 61
977 JOINT EFFUSION 61
978 RESPIRATORY TRACT INFECTION VIRAL 61
979 SKIN ODOUR ABNORMAL 61
980 TRANSPLANT 61
981 ANURIA 60
982 CROHN^S DISEASE 60
983 FACE INJURY 60
984 FRUSTRATION TOLERANCE DECREASED 60
985 HALLUCINATION, VISUAL 60
986 HYSTERECTOMY 60
987 SCAB 60
988 SPINAL DISORDER 60
989 ULCER HAEMORRHAGE 60
990 VITAMIN D DEFICIENCY 60
991 ACNE 59
992 AORTIC STENOSIS 59
993 APPLICATION SITE ERYTHEMA 59
994 CONJUNCTIVITIS 59
995 DYSLIPIDAEMIA 59
996 ECHOCARDIOGRAM ABNORMAL 59
997 HYPERCHOLESTEROLAEMIA 59
998 INCREASED APPETITE 59
999 INCREASED TENDENCY TO BRUISE 59